12/07/2016 - 10:45am

In an interview with Time published Tuesday morning to accompany his being chosen as the magazine’s “Person of the Year,” President-elect Donald Trump told the magazine that one of his goals as president is lowering the cost of prescription drugs.  

12/06/2016 - 1:51pm

The “Outlook for Global Medicines Through 2021: Balancing Cost and Value” report projects that total global spending will be close to $1.5 trillion on an invoice price basis through 2021.

12/02/2016 - 12:50pm

The drug was approved by the Food and Drug Administration to treat multiple myeloma in patients who have received at least one other treatment.

11/30/2016 - 11:09am

The Rxight test provides information on medications covering 14 therapeutic classes, including pain, blood pressure, blood thinner, ADHD, anxiety, depression, diabetes, cancer, respiratory issues and other medications.

11/28/2016 - 12:45pm

Impax announced Monday that it had appointed J. Kevin Buchi, CEO of TetraLogic Pharmaceuticals, to its board of directors. 

11/28/2016 - 12:09pm

Both companies have confirmed that they are in preliminary discussions. 

11/22/2016 - 1:36pm

Xultophy was approved the same day as Sanofi’s Soliqua 100/33, and the two are among the first in a new class of drugs that combine a GLP-1 agonist and long-lasting insulin.

11/22/2016 - 12:29pm

Soliqua 100/33 combines Lantus and lixisenatide, a GLP-1 receptor agonist, in a once-daily injection.

11/21/2016 - 1:01pm

Diplomat has begun dispensing Shire’s recently launched primary immunodeficiency treatment.